{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T13:06:41Z","timestamp":1779368801205,"version":"3.53.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T00:00:00Z","timestamp":1365033600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1007\/s00380-013-0346-x","type":"journal-article","created":{"date-parts":[[2013,4,3]],"date-time":"2013-04-03T03:33:01Z","timestamp":1364959981000},"page":"186-190","source":"Crossref","is-referenced-by-count":28,"title":["Higher serum uric acid and lipoprotein(a) are correlated with coronary spasm"],"prefix":"10.1007","volume":"29","author":[{"given":"Masami","family":"Nishino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuharu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Taniike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiko","family":"Makino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyasu","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Egami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryu","family":"Shutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Tanouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,4]]},"reference":[{"key":"346_CR1","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1161\/01.CIR.74.5.955","volume":"74","author":"H Yasue","year":"1986","unstructured":"Yasue H, Horio Y, Nakamura N, Fujii H, Imoto N, Sonoda R, Kugiyama K, Obata K, Morikami Y, Kimura T (1986) Induction of coronary artery spasm by acetylcholine in patients with variant angina: possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm. Circulation 74:955\u2013963","journal-title":"Circulation"},{"key":"346_CR2","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1161\/01.CIR.74.6.1255","volume":"74","author":"JC Kaski","year":"1986","unstructured":"Kaski JC, Crea F, Meran D, Rodriguez L, Araujo L, Chierchia S, Davies G, Maseri A (1986) Local coronary supersensitivity to diverse vasoconstrictive stimuli in patients with variant angina. Circulation 74:1255\u20131265","journal-title":"Circulation"},{"key":"346_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.CIR.78.1.1","volume":"78","author":"H Yasue","year":"1988","unstructured":"Yasue H, Takizawa A, Nagao M, Nishida S, Horie M, Kubota J, Omote S, Takaoka K, Okumura K (1988) Long-term prognosis for patients with variant angina and influential factors. Circulation 78:1\u20139","journal-title":"Circulation"},{"key":"346_CR4","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJM199205283262202","volume":"326","author":"RJ Myerburg","year":"1992","unstructured":"Myerburg RJ, Kessler KM, Mallon SM, Cox MM, deMarchena E, Interian AJ, Castellanos A (1992) Life-threatening ventricular arrhythmias in patients with silent myocardial ischemia due to coronary-artery spasm. N Engl J Med 326:1451\u20131455","journal-title":"N Engl J Med"},{"key":"346_CR5","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/0140-6736(93)92850-S","volume":"342","author":"M Bory","year":"1993","unstructured":"Bory M, Panagides D, Desfossez L (1993) Coronary artery spasm in myocardial infarction. Lancet 342:436","journal-title":"Lancet"},{"key":"346_CR6","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/S0735-1097(97)00236-2","volume":"30","author":"K Kugiyama","year":"1997","unstructured":"Kugiyama K, Ohgushi M, Motoyama T, Sugiyama S, Ogawa H, Yoshimura M, Inobe Y, Hirashima O, Kawano H, Soejima H, Yasue H (1997) Nitric oxide-mediated flow-dependent dilation is impaired in coronary arteries in patients with coronary spastic angina. J Am Coll Cardiol 30:920\u2013926","journal-title":"J Am Coll Cardiol"},{"key":"346_CR7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.semnephrol.2004.09.007","volume":"25","author":"J Kanellis","year":"2005","unstructured":"Kanellis J, Kang DH (2005) Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. Semin Nephrol 25:39\u201342","journal-title":"Semin Nephrol"},{"key":"346_CR8","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1111\/j.1523-1755.2005.00273.x","volume":"67","author":"UM Khosla","year":"2005","unstructured":"Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W, Krotova K, Block ER, Prabhakar S, Johnson RJ (2005) Hyperuricemia induces endothelial dysfunction. Kidney Int 67:1739\u20131742","journal-title":"Kidney Int"},{"key":"346_CR9","doi-asserted-by":"crossref","first-page":"F1134","DOI":"10.1152\/ajprenal.00104.2008","volume":"295","author":"LG Sanchez-Lozada","year":"2008","unstructured":"Sanchez-Lozada LG, Soto V, Tapia E, Avila-Casado C, Sautin YY, Nakagawa T, Franco M, Rodriguez-Iturbe B, Johnson RJ (2008) Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia. Am J Physiol Ren Physiol 295:F1134\u2013F1141","journal-title":"Am J Physiol Ren Physiol"},{"key":"346_CR10","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1253\/circj.69.521","volume":"69","author":"K Tsuchida","year":"2005","unstructured":"Tsuchida K, Hori T, Tanabe N, Makiyama Y, Ozawa T, Saigawa T, Watanabe R, Tanaka T, Nasuno A, Fukunaga H, Mezaki T, Nakamura Y, Aizawa Y (2005) Relationship between serum lipoprotein(a) concentrations and coronary vasomotion in coronary spastic angina. Circ J 69:521\u2013525","journal-title":"Circ J"},{"key":"346_CR11","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/0735-1097(95)00321-5","volume":"26","author":"Y Tsurumi","year":"1995","unstructured":"Tsurumi Y, Nagashima H, Ichikawa K, Sumiyoshi T, Hosoda S (1995) Influence of plasma lipoprotein (a) levels on coronary vasomotor response to acetylcholine. J Am Coll Cardiol 26:1242\u20131250","journal-title":"J Am Coll Cardiol"},{"key":"346_CR12","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/jama.295.2.180","volume":"295","author":"DL Bhatt","year":"2006","unstructured":"Bhatt DL, Steg PG, Ohman EM, Hirsch AT, Ikeda Y, Mas JL, Goto S, Liau CS, Richard AJ, Rother J, Wilson PW (2006) International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 295:180\u2013189","journal-title":"JAMA"},{"key":"346_CR13","doi-asserted-by":"crossref","unstructured":"(2002) New criteria for \u2018obesity disease\u2019 in Japan. Circ J 66:987\u2013992","DOI":"10.1253\/circj.66.987"},{"key":"346_CR14","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"RM Lang","year":"2005","unstructured":"Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography\u2019s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440\u20131463","journal-title":"J Am Soc Echocardiogr"},{"key":"346_CR15","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1253\/circj.CJ-10-74-0802","volume":"74","author":"JWG Jcs","year":"2010","unstructured":"Jcs JWG (2010) Guidelines for diagnosis and treatment of patients with vasospastic angina (coronary spastic angina) (JCS 2008): digest version. Circ J 74:1745\u20131762","journal-title":"Circ J"},{"key":"346_CR16","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.jacc.2011.05.044","volume":"58","author":"F Crea","year":"2011","unstructured":"Crea F, Lanza GA (2011) New light on a forgotten disease: vasospastic angina. J Am Coll Cardiol 58:1238\u20131240","journal-title":"J Am Coll Cardiol"},{"key":"346_CR17","doi-asserted-by":"crossref","first-page":"760","DOI":"10.2169\/internalmedicine.36.760","volume":"36","author":"H Yasue","year":"1997","unstructured":"Yasue H, Kugiyama K (1997) Coronary spasm: clinical features and pathogenesis. Intern Med 36:760\u2013765","journal-title":"Intern Med"},{"key":"346_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1253\/jcj.64.1","volume":"64","author":"H Shimokawa","year":"2000","unstructured":"Shimokawa H (2000) Cellular and molecular mechanisms of coronary artery spasm: lessons from animal models. Jpn Circ J 64:1\u201312","journal-title":"Jpn Circ J"},{"key":"346_CR19","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1161\/01.CIR.94.3.266","volume":"94","author":"K Kugiyama","year":"1996","unstructured":"Kugiyama K, Yasue H, Okumura K, Ogawa H, Fujimoto K, Nakao K, Yoshimura M, Motoyama T, Inobe Y, Kawano H (1996) Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. Circulation 94:266\u2013271","journal-title":"Circulation"},{"key":"346_CR20","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1016\/S0021-9258(19)50640-8","volume":"267","author":"ME Haberland","year":"1992","unstructured":"Haberland ME, Fless GM, Scanu AM, Fogelman AM (1992) Malondialdehyde modification of lipoprotein(a) produces avid uptake by human monocyte-macrophages. J Biol Chem 267:4143\u20134151","journal-title":"J Biol Chem"},{"key":"346_CR21","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/330132a0","volume":"330","author":"JW McLean","year":"1987","unstructured":"McLean JW, Tomlinson JE, Kuang WJ, Eaton DL, Chen EY, Fless GM, Scanu AM, Lawn RM (1987) cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 330:132\u2013137","journal-title":"Nature"},{"key":"346_CR22","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/339303a0","volume":"339","author":"KA Hajjar","year":"1989","unstructured":"Hajjar KA, Gavish D, Breslow JL, Nachman RL (1989) Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature 339:303\u2013305","journal-title":"Nature"},{"key":"346_CR23","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/BF00201550","volume":"86","author":"C Sandholzer","year":"1991","unstructured":"Sandholzer C, Hallman DM, Saha N, Sigurdsson G, Lackner C, Csaszar A, Boerwinkle E, Utermann G (1991) Effects of the apolipoprotein(a) size polymorphism on the lipoprotein(a) concentration in 7 ethnic groups. Hum Genet 86:607\u2013614","journal-title":"Hum Genet"},{"key":"346_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0021-9150(92)90032-C","volume":"96","author":"A Abe","year":"1992","unstructured":"Abe A, Noma A (1992) Studies on apolipoprotein(a) phenotypes. Part 1. Phenotype frequencies in a healthy Japanese population. Atherosclerosis 96:1\u20138","journal-title":"Atherosclerosis"},{"key":"346_CR25","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1161\/01.HYP.0000069700.62727.C5","volume":"41","author":"RJ Johnson","year":"2003","unstructured":"Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, Tuttle KR, Rodriguez-Iturbe B, Herrera-Acosta J, Mazzali M (2003) Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 41:1183\u20131190","journal-title":"Hypertension"},{"key":"346_CR26","author":"T Senmaru","year":"2012","unstructured":"Senmaru T, Fukui M, Tanaka M, Sakabe K, Ushigome E, Asano M, Yamazaki M, Hasegawa G, Nakamura N (2012) N-terminal pro-brain natriuretic peptide could be a marker of subclinical atherosclerosis in patients with type 2 diabetes. Heart Vessels. doi: 10.1007\/s00380-011-0227-0","journal-title":"Heart Vessels"},{"key":"346_CR27","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s00380-011-0138-0","volume":"27","author":"Y Mineoka","year":"2012","unstructured":"Mineoka Y, Fukui M, Tanaka M, Tomiyasu K, Akabame S, Nakano K, Yamazaki M, Hasegawa G, Oda Y, Nakamura N (2012) Relationship between cardio-ankle vascular index (CAVI) and coronary artery calcification (CAC) in patients with type 2 diabetes mellitus. Heart Vessels 27:160\u2013165","journal-title":"Heart Vessels"},{"key":"346_CR28","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1053\/euhj.2002.3343","volume":"23","author":"WS Waring","year":"2002","unstructured":"Waring WS, Maxwell SR, Webb DJ (2002) Uric acid concentrations and the mechanisms of cardiovascular disease. Eur Heart J 23:1888\u20131889","journal-title":"Eur Heart J"},{"key":"346_CR29","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.amjcard.2004.06.032","volume":"94","author":"G Mercuro","year":"2004","unstructured":"Mercuro G, Vitale C, Cerquetani E, Zoncu S, Deidda M, Fini M, Rosano GM (2004) Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk. Am J Cardiol 94:932\u2013935","journal-title":"Am J Cardiol"},{"key":"346_CR30","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/01.CIR.0000022140.61460.1D","volume":"106","author":"CA Farquharson","year":"2002","unstructured":"Farquharson CA, Butler R, Hill A, Belch JJ, Struthers AD (2002) Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation 106:221\u2013226","journal-title":"Circulation"},{"key":"346_CR31","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1161\/01.CIR.0000017502.58595.ED","volume":"105","author":"W Doehner","year":"2002","unstructured":"Doehner W, Schoene N, Rauchhaus M, Leyva-Leon F, Pavitt DV, Reaveley DA, Schuler G, Coats AJ, Anker SD, Hambrecht R (2002) Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies. Circulation 105:2619\u20132624","journal-title":"Circulation"},{"key":"346_CR32","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0002-8703(91)90950-M","volume":"121","author":"WD Johnson","year":"1991","unstructured":"Johnson WD, Kayser KL, Brenowitz JB, Saedi SF (1991) A randomized controlled trial of allopurinol in coronary bypass surgery. Am Heart J 121:20\u201324","journal-title":"Am Heart J"},{"key":"346_CR33","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0022-5223(19)36703-0","volume":"101","author":"K Tabayashi","year":"1991","unstructured":"Tabayashi K, Suzuki Y, Nagamine S, Ito Y, Sekino Y, Mohri H (1991) A clinical trial of allopurinol (Zyloric) for myocardial protection. J Thorac Cardiovasc Surg 101:713\u2013718","journal-title":"J Thorac Cardiovasc Surg"},{"key":"346_CR34","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1161\/hc4501.098928","volume":"104","author":"TP Cappola","year":"2001","unstructured":"Cappola TP, Kass DA, Nelson GS, Berger RD, Rosas GO, Kobeissi ZA, Marban E, Hare JM (2001) Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy. Circulation 104:2407\u20132411","journal-title":"Circulation"},{"key":"346_CR35","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/S0140-6736(10)60391-1","volume":"375","author":"A Noman","year":"2010","unstructured":"Noman A, Ang DS, Ogston S, Lang CC, Struthers AD (2010) Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial. Lancet 375:2161\u20132167","journal-title":"Lancet"},{"key":"346_CR36","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.jacc.2010.12.052","volume":"58","author":"NS Rajendra","year":"2011","unstructured":"Rajendra NS, Ireland S, George J, Belch JJ, Lang CC, Struthers AD (2011) Mechanistic insights into the therapeutic use of high-dose allopurinol in angina pectoris. J Am Coll Cardiol 58:820\u2013828","journal-title":"J Am Coll Cardiol"},{"key":"346_CR37","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.2337\/dc10-1007","volume":"33","author":"TC Rodrigues","year":"2010","unstructured":"Rodrigues TC, Maahs DM, Johnson RJ, Jalal DI, Kinney GL, Rivard C, Rewers M, Snell-Bergeon JK (2010) Serum uric acid predicts progression of subclinical coronary atherosclerosis in individuals without renal disease. Diabetes Care 33:2471\u20132473","journal-title":"Diabetes Care"},{"key":"346_CR38","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/01.CIR.87.1.76","volume":"87","author":"M Sugiishi","year":"1993","unstructured":"Sugiishi M, Takatsu F (1993) Cigarette smoking is a major risk factor for coronary spasm. Circulation 87:76\u201379","journal-title":"Circulation"},{"key":"346_CR39","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1378\/chest.118.6.1690","volume":"118","author":"H Teragawa","year":"2000","unstructured":"Teragawa H, Kato M, Yamagata T, Matsuura H, Kajiyama G (2000) The preventive effect of magnesium on coronary spasm in patients with vasospastic angina. Chest 118:1690\u20131695","journal-title":"Chest"},{"key":"346_CR40","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.jacc.2007.12.049","volume":"51","author":"H Yasue","year":"2008","unstructured":"Yasue H, Mizuno Y, Harada E, Itoh T, Nakagawa H, Nakayama M, Ogawa H, Tayama S, Honda T, Hokimoto S, Ohshima S, Hokamura Y, Kugiyama K, Horie M, Yoshimura M, Harada M, Uemura S, Saito Y (2008) Effects of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, fluvastatin, on coronary spasm after withdrawal of calcium-channel blockers. J Am Coll Cardiol 51:1742\u20131748","journal-title":"J Am Coll Cardiol"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-013-0346-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00380-013-0346-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-013-0346-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T22:02:30Z","timestamp":1644703350000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00380-013-0346-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,4]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["346"],"URL":"https:\/\/doi.org\/10.1007\/s00380-013-0346-x","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"value":"0910-8327","type":"print"},{"value":"1615-2573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,4]]}}}